Maxeler: Maxeler Technologies Licenses Healthcare Technologies

London, United Kingdom, January 25, 2020 --(PR.com)-- Maxeler Technologies recently licensed novel, "explainable" AI-driven prescription prediction technologies from Georgetown University. Using the patent-pending, technology developed at Georgetown's Information Retrieval Laboratory under Professor Ophir Frieder, Maxeler intends to work with the researchers at Georgetown to productize scalable, patient-specific, prescription selectors, reducing drug resistance, thereby improving patient care. Frieder, the Robert L. McDevitt, K.S.G., K.C.H.S. and Catherine H. McDevitt L.C.H.S. Professor in Computer Science and Information Processing, is the lead inventor of the technology.The AI-driven prescription predictive models suggest effective medications that minimize adverse effects. Many artificial intelligence-based efforts focus on the aforementioned problem but do so using "black box" approaches which solve the problem, but fail to provide interpretability. Since prescribing physicians are hesitant to rely on suggestions whose derivations are ...Full story available on Benzinga.com